Clinical trial
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
NCT04823741 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 11, 2022
- Completion date
- February 11, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gene abnormality, mesothelioma, malignant, pleural mesothelioma